Jeffrey McKenna
Director Novartis
Experienced medicinal chemist having worked in Biotech and Big Pharma. Most recently working to exploit new modalities to answer key drug discovery strategies and drug novel targets – this focus has driven science forward in the TPD and covalency areas and spawned key academic collaborations
Seminars
Thursday 22nd October 2026
The Evolution of the Novartis Covalent Library & Its Application
11:30 am
- Critical understanding of the chemical content of a library dictates success and strategies
- The path to augment the compound collections will be discussed along with recent highlighted successes following screening campaigns of this content
- Focus areas will be highlighted and innovation mechanisms discussed
